These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18032361)

  • 21. [New medications; ziconotide].
    Cohen AF; van Bronswijk H
    Ned Tijdschr Geneeskd; 2006 Nov; 150(44):2427-8. PubMed ID: 17131701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propoxyphene and pain management in the elderly.
    Mort JR; Schroeder SD
    S D Med; 2009 Nov; 62(11):433-5. PubMed ID: 20128173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics.
    Sanford M
    CNS Drugs; 2013 Nov; 27(11):989-1002. PubMed ID: 23999971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal therapy: what has changed with the introduction of ziconotide.
    Kress HG; Simpson KH; Marchettini P; Ver Donck A; Varrassi G
    Pain Pract; 2009; 9(5):338-47. PubMed ID: 19740270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature.
    Webster LR
    Pain Med; 2015 Jul; 16(7):1265-77. PubMed ID: 25645109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term intrathecal ziconotide for chronic pain: an open-label study.
    Webster LR; Fisher R; Charapata S; Wallace MS
    J Pain Symptom Manage; 2009 Mar; 37(3):363-72. PubMed ID: 18715748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity.
    Barkin RL; Barkin SJ; Barkin DS
    Am J Ther; 2006; 13(6):534-42. PubMed ID: 17122535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Close vote by FDA advisers favors propoxyphene withdrawal.
    Traynor K
    Am J Health Syst Pharm; 2009 Mar; 66(6):518-20. PubMed ID: 19265176
    [No Abstract]   [Full Text] [Related]  

  • 29. The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain.
    Pope JE; Deer TR; Amirdelfan K; McRoberts WP; Azeem N
    Curr Neuropharmacol; 2017; 15(2):206-216. PubMed ID: 26861471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New aspects in performing interventional techniques for chronic pain.
    Zuurmond WW; Perez RS; Loer SA
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):132-6. PubMed ID: 18685354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dextropropoxyphene: withdrawn in the EU. Withdrawn from pharmacies in France.
    Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19746528
    [No Abstract]   [Full Text] [Related]  

  • 32. [Recommendations for the management of chronic pain by intrathecal ziconotide].
    Tronnier V; Hofacker W; Ilias W; Kleinmann B; Koulousakis A; Kress HG; Likar R; Lux EA; Müller-Schwefe G; Schütze G; Uberall M
    MMW Fortschr Med; 2010 Oct; 152 Suppl 3():106-9. PubMed ID: 21595155
    [No Abstract]   [Full Text] [Related]  

  • 33. Dextropropoxyphene: withdrawal from the US market requested: harmful drug.
    Prescrire Int; 2009 Aug; 18(102):166-7. PubMed ID: 19746529
    [No Abstract]   [Full Text] [Related]  

  • 34. Weak opiate analgesics: modest practical merits.
    Prescrire Int; 2004 Feb; 13(69):22-5. PubMed ID: 15055224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ziconotide: an innovative alternative for intense chronic neuropathic pain].
    Valía-Vera JC; Villanueva VL; Asensio-Samper JM; López-Alarcón MD; de Andrés JA
    Rev Neurol; 2007 Dec 1-15; 45(11):665-9. PubMed ID: 18050098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elan: ziconotide review focused on off-label uses.
    Narayana AK
    Am J Hosp Palliat Care; 2005; 22(6):408. PubMed ID: 16323709
    [No Abstract]   [Full Text] [Related]  

  • 37. Why pick on propoxyphene? The evidence demands it.
    Hutchison LC
    J Ark Med Soc; 2010 Aug; 107(2):36-7. PubMed ID: 20806582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of dextropropoxyphene + acetaminophen fixed-dose combination in psychiatric hospital in Bahrain: is there a cause for concern?
    Al Khaja KA; Al-Haddad MK; Al-Offi AR; Abdulraheem MH; Sequeira RP
    Fundam Clin Pharmacol; 2009 Apr; 23(2):253-8. PubMed ID: 19645819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal pain pumps: indications, patient selection, techniques, and outcomes.
    Bolash R; Mekhail N
    Neurosurg Clin N Am; 2014 Oct; 25(4):735-42. PubMed ID: 25240660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ziconotide: can we use it in palliative care?
    Prommer EE
    Am J Hosp Palliat Care; 2005; 22(5):369-74. PubMed ID: 16225359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.